LNAI

Lunai Bioworks Inc.

—

Insider Sentiment

Last purchase: 2022-05-18
Last sale: 2024-07-29
Shares purchased (TTM): 0
Shares sold (TTM): 213,550

Buy ratio (TTM)0.0%

Institutional Sentiment

As of: 2026-06-30
Institutional shares owned: 145,804
Shares outstanding: 24,994,200
Ownership: 0.58%

-85.97% Y/Y

Earnings Market Reaction

Filing date: 2026-05-15
Price on filing date: —
1-month reaction: 19.16%
3-month reaction: -5.64%

Drift continued4/10 (40%)

Faded / reversed6/10 (60%)

Export data

Recent filings

10-Q2026-03-31Filed 2026-05-15
10-Q2025-12-31Filed 2026-02-17
10-Q2025-09-30Filed 2025-11-14
10-K2025-06-30Filed 2025-09-29
10-Q2025-03-31Filed 2025-05-15
10-Q2024-12-31Filed 2025-02-19
10-Q2024-09-30Filed 2024-11-14
10-K2024-06-30Filed 2024-10-10
10-Q2024-03-31Filed 2024-05-15
10-Q2023-12-31Filed 2024-02-14
10-Q2023-09-30Filed 2023-11-14
10-K2023-06-30Filed 2023-10-02

Financial statements beyond 3 years are for subscribers only.

Unlock 17+ years of income statements, balance sheets, and cash flow statements

Start 7-day free trial

Balance Sheet

Values in millions ($)

Line item	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30	2024-06-30	2024-03-31	2023-12-31	2023-09-30	2023-06-30
Assets
Cash And Cash Equivalents At Carrying Value	3	0	1	0	1	0	0	0	0	0	1	2
Assets Current
Assets Current	4	1	1	1	4	2	2	2	1	2	2	3
Receivables Net Current	-	-	-	-	-	-	-	-	-	1	1	-
Accounts Receivable Net Current	-	-	-	-	1	-	-	-	-	-	-	-
Insurance Settlements Receivable Current	-	-	-	0	0	0	1	1	-	-	-	0
Prepaid Expense And Other Assets Current	-	-	-	-	1	1	0	-	-	-	-	-
Equity Securities Fv Ni	-	-	-	0	1	-	-	-	-	-	-	-
Other Prepaid Expense Current	1	0	0	1	-	-	-	1	1	1	0	1
Property Plant And Equipment Net	0	0	0	0	0	0	0	0	0	0	0	1
Other Intangible Assets Net	-	-	-	-	0	0	0	-	-	-	-	-
Finite Lived Intangible Assets Net	-	-	-	-	-	-	-	0	0	0	0	0
Indefinite Lived Intangible Assets Excluding Goodwill	-	-	-	-	-	-	-	0	11	43	43	43
Assets Noncurrent
Capitalized Computer Software Gross	0	0	0	0	-	-	-	-	-	-	-	-
Finite Lived Trademarks Gross	0	0	0	0	-	-	-	-	-	-	-	-
Goodwill	6	6	6	6	113	108	118	159	164	12	12	12
Operating Lease Right Of Use Asset	-	-	-	1	1	1	1	1	1	1	1	1
Deposits Assets Noncurrent	0	0	0	-	0	0	0	0	0	0	0	0
Other Assets Noncurrent	6	6	6	7	114	109	119	161	176	55	55	55
Assets	10	7	7	8	118	111	122	163	178	58	58	58
Liabilities And Stockholders Equity
Accounts Payable Trade Current	13	12	12	13	12	11	11	9	8	6	5	5
Liabilities Current
Accrued Liabilities Current	5	5	5	6	6	6	5	5	4	1	1	1
Liabilities Current	19	20	20	29	29	29	23	30	21	14	10	11
Other Liabilities Current	0	0	0	0	1	1	0	0	1	1	-	0
Convertible Notes Payable Current	-	-	-	-	0	0	0	-	-	-	-	-
Convertible Notes Payable	0	0	0	0	-	-	-	0	4	3	1	0
Operating Lease Liability Current	0	0	0	0	1	1	1	0	0	0	0	0
Notes Payable Current	-	-	-	-	-	-	-	-	-	-	-	5
Notes Payable	-	1	1	4	-	-	-	-	-	-	-	-
Liabilities Noncurrent
Liabilities Noncurrent	0	0	0	0	0	1	1	1	23	1	1	1
Operating Lease Liability Noncurrent	0	0	0	0	0	1	1	1	1	1	1	1
Liabilities	19	20	20	30	29	29	24	31	44	14	11	12
Preferred Stock Value	0	-	0	0	-	-	0	0	0	0	0	0
Common Stock Value	0	0	0	0	0	0	0	0	0	0	0	0
Stockholders Equity
Additional Paid In Capital	503	496	495	478	471	470	468	465	450	301	300	291
Stockholders Equity	-10	-14	-13	-21	88	82	98	132	134	44	47	47
Retained Earnings Accumulated Deficit	-512	-509	-508	-510	-384	-384	-377	-332	-317	-258	-253	-244
Accumulated Other Comprehensive Income Loss Net Of Tax	-0	-0	-0	11	1	-4	6	-0	1	-0	-0	-0
Liabilities And Stockholders Equity	10	7	7	8	118	111	122	163	178	58	58	58
Preferred Stock Par Or Stated Value Per Share	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Preferred Stock Shares Authorized	10	10	10	10	10	10	10	10	10	10	10	10
Preferred Stock Shares Issued	0	0	0	0	0	0	0	0	0	1	1	0
Preferred Stock Shares Outstanding	0	0	0	0	0	0	0	0	0	1	1	0
Common Stock Par Or Stated Value Per Share	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Common Stock Shares Authorized	350	350	350	350	350	350	350	350	350	100	100	350
Common Stock Shares Issued	4	24	80	18	16	16	16	16	15	7	7	6
Shares Outstanding	36	24	23	18	16	16	16	16	15	7	7	6

Select a line item above to chart it.

Recent filings

10-Q2026-03-31Filed 2026-05-15
10-Q2025-12-31Filed 2026-02-17
10-Q2025-09-30Filed 2025-11-14
10-K2025-06-30Filed 2025-09-29
10-Q2025-03-31Filed 2025-05-15
10-Q2024-12-31Filed 2025-02-19
10-Q2024-09-30Filed 2024-11-14
10-K2024-06-30Filed 2024-10-10
10-Q2024-03-31Filed 2024-05-15
10-Q2023-12-31Filed 2024-02-14
10-Q2023-09-30Filed 2023-11-14
10-K2023-06-30Filed 2023-10-02

Financial statements beyond 3 years are for subscribers only.

Unlock 17+ years of income statements, balance sheets, and cash flow statements

Start 7-day free trial

Lunai Bioworks Inc. (LNAI) — SEC Financial Statements & Analysis

Lunai Bioworks Inc. (LNAI) is a pharmaceutical preparations company, incorporated in DE. Lunai Bioworks Inc. trades on Nasdaq as: LNAI. Lunai Bioworks Inc. (LNAI)'s most recent SEC filing is a Form 10-Q for the period ended 2026-03-31, filed with the SEC on 2026-05-15. Based on that filing, Lunai Bioworks Inc. carries a market cap of $81.58M, a P/E ratio of -0.64x, a P/B ratio of -8.54x, a P/S ratio of 3895.57x, an enterprise value of $78.43M, and an EV/EBITDA multiple of -0.59x. On profitability, it posts an operating margin of -637607.08%, a net margin of -612568.10%, a Return on Equity (ROE) of -325.46%, a Return on Assets (ROA) of -201.09%, and a Return on Invested Capital (ROIC) of -71.37%. Per share, it reports EPS of $-5.13, diluted EPS of $-5.13, free cash flow per share of $-0.21, and a dividend per share of $0.00. Over the trailing year, it posted net income growth of 91.45% year-over-year and EPS growth of 24.34% year-over-year. On the balance sheet, it maintains a current ratio of 0.19x, a quick ratio of 0.19x, working capital of $-15.55M, a debt-to-equity ratio of -2.03x, a debt ratio of 1.97, an interest coverage ratio of -247.28x, free cash flow of $-5.26M (TTM), and net debt of $-3.16M. Figures sourced from SEC EDGAR.

Market Cap: $81.58M
P/E TTM: -0.64x
EPS TTM: $-5.13
P/B TTM: -8.54x
ROE TTM: -325.46%
ROA TTM: -201.09%
Debt To Equity: -2.03x
Free Cash Flow TTM: $-5.26M

Data as of 2026-03-31 · Source: SEC EDGAR

Frequently Asked Questions

What industry is Lunai Bioworks Inc. in?

Lunai Bioworks Inc. (LNAI) operates in the Pharmaceutical Preparations industry.

What exchange does LNAI trade on?

Lunai Bioworks Inc. (LNAI) trades on the Nasdaq.

Where is Lunai Bioworks Inc. incorporated?

Lunai Bioworks Inc. is incorporated in DE.

When was Lunai Bioworks Inc. (LNAI)'s most recent SEC filing?

Lunai Bioworks Inc. (LNAI)'s most recent SEC filing is a Form 10-Q for the period ended 2026-03-31, filed with the SEC on 2026-05-15.

What is LNAI's market cap?

Lunai Bioworks Inc. (LNAI) has a market capitalization of $81.58M as of 2026-03-31.

What is LNAI's EPS (earnings per share)?

Lunai Bioworks Inc. (LNAI)'s trailing twelve month EPS is $-5.13 as of 2026-03-31.

What is LNAI's ROE (return on equity)?

Lunai Bioworks Inc. (LNAI)'s trailing twelve month Return on Equity (ROE) is -325.46% as of 2026-03-31.

What is LNAI's ROA (return on assets)?

Lunai Bioworks Inc. (LNAI)'s trailing twelve month Return on Assets (ROA) is -201.09% as of 2026-03-31.

What is LNAI's ROIC (return on invested capital)?

Lunai Bioworks Inc. (LNAI)'s trailing twelve month Return on Invested Capital (ROIC) is -71.37% as of 2025-03-31.

What is LNAI's EV/EBITDA?

Lunai Bioworks Inc. (LNAI)'s trailing twelve month EV/EBITDA is -0.59x as of 2026-03-31.

Wall Street's data.
Main Street's price.

Start 7-day free trial

LNAI

Company Information

Insider Sentiment

Institutional Sentiment

Earnings Market Reaction

Recent filings

Recent filings

Lunai Bioworks Inc. (LNAI) — SEC Financial Statements & Analysis

Frequently Asked Questions

Wall Street's data.Main Street's price.

Wall Street's data.
Main Street's price.